Preparation and application of novel pH and glucose dual-responsive polymer and hydrogel

Through the design and preparation of the new polymer PLP-PBA, the problem of insufficient response in existing glucose-sensitive drug systems under physiological conditions is solved, and the glucose and pH dual response at physiological pH is achieved. Insulin suitable for diabetes treatment is suitable for diabetes treatment Delivery vector.

CN118994567APending Publication Date: 2024-11-22NANJING TECH UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411104102.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing glucose-sensitive drug systems such as benzoic acid, contaminoglobulin A and glucose oxidase have problems such as inhibition of activity, poor stability, immunotoxicity and long response time, which limits their application in diabetes treatment, especially in physiology. Glucose response is insufficient under conditions.

Method used

Develop a new pH and glucose biresponsive polymer PLP-PBA, which forms a borate bond with glucose under physiological pH conditions by copolymerizing polylysine isophthalamide with aminophenylboric acid derivatives. Polymers were prepared by amidation reaction to prepare hydrogels with good glucose responsiveness.

Benefits of technology

Good glucose responsiveness and pH responsiveness under physiological pH conditions are achieved. The polymer shrinks its particle size under acidic conditions, forms porous microstructures and swells, and is suitable as a delivery vehicle for insulin drugs for the treatment of diabetes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994567A_ABST
    Figure CN118994567A_ABST
Patent Text Reader

Abstract

The invention discloses preparation and application of a novel pH and glucose dual-responsive polymer and hydrogel. The polymer disclosed by the invention is poly (lysine-isophthalamide) PLP-PBA grafted with an aminophenylboronic acid derivative, and the poly (lysine-isophthalamide) and the aminophenylboronic acid derivative are subjected to amidation reaction in a solvent under the action of a coupling reagent and a catalyst, so that the polymer disclosed by the invention can be obtained. The hydrogel provided by the invention is obtained by forming an amido bond between the polymer and L-lysine methyl ester dihydrochloride through catalysis. The hydrogel disclosed by the invention has good pH responsiveness and glucose responsiveness, and can be used as a delivery carrier of insulin drugs for preparing drugs for treating diabetes mellitus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of polymer chemistry and material chemistry, and specifically relates to the preparation and application of a novel pH and glucose dual-responsive polymer and hydrogel. Background Art

[0002] Diabetes is a metabolic disease characterized by high blood sugar. Insulin is one of the main drugs for the treatment of type I and some type II diabetes. However, insulin injection is painful and inconvenient, and overdose can cause hypoglycemia and even endanger life. Monitoring of glucose concentration and controlled release of insulin are the main means of diabetes treatment. Currently, there are three glucose-sensitive drug systems: phenylboronic acid (PBA) and its derivatives, concanavalin A (ConA) and glucose oxidase (GO x ). GO x Under physiological conditions, glucose can be catalyzed to produce gluconic acid and hydrogen peroxide (H2O2). The increase of H2O2 and gluconic acid in the environment will inhibit GO. x activity, resulting in decreased glucose sensitivity. In addition, H2O2 is considered a toxic intermediate that inhibits cell growth and causes cell death. ConA has problems such as poor stability, protein denaturation and inactivation, immunotoxicity, and long response time, which also limit its application. PBA can reversibly form a borate ester bond with glucose. As a synthetic glucose-sensitive substance, it does not produce harmful byproducts, does not induce immunotoxicity, does not have denaturation problems, and is stable in long-term storage.

[0003] Phenylboronic acid systems have received extensive attention in the field of glucose responsiveness and controlled release of insulin, and there are a large number of reports on polymers, micelles, and gel systems containing phenylboronic acid. PBA exists in two dynamic forms in aqueous solution, one is a hydrophobic, uncharged triangular planar structure, and the other is a hydrophilic, negatively charged tetrahedral structure, which can combine with cis-1,2- or -1,3-diol compounds (such as glucose) to form borate esters. Once glucose is introduced into the aqueous solution system, the equilibrium shifts to the right to form an anionic tetrahedral structure, increasing the hydrophilicity and negative charge density of PBA. In the presence of glucose, ionized phenylboronic acid can form a stable complex with glucose through the phenylboronic acid ester bond, causing the equilibrium to move in the direction of ionization, increasing the degree of ionization, and increasing solubility. Due to the pK of phenylboronic acid a The value is between 8 and 9. Phenylboronic acid has a low binding capacity with glucose under normal physiological conditions, which greatly limits the application of glucose-responsive systems containing phenylboronic acid. Summary of the invention

[0004] The purpose of the present invention is to solve the problems existing in the prior art and to provide a novel pH and glucose dual-responsive polymer and hydrogel preparation and application thereof.

[0005] The purpose of the present invention is achieved through the following technical solutions:

[0006] A novel pH and glucose dual-responsive polymer is polylysine isophthalamide PLP-PBA grafted with aminophenylboronic acid derivatives, and its structure is shown in the following formula:

[0007]

[0008] Among them, one of R1-R5 is B(OH)2, and the other four are one or more of hydrogen, halogen, amino, hydroxyl, methyl, ethyl, carboxyl, aminomethyl, aminoethyl, formyl, and formylamino. In the formula, x and y are lysine isophthalamide units without grafting aminophenylboronic acid derivatives and lysine isophthalamide units grafted with aminophenylboronic acid derivatives, respectively.

[0009] Preferably, the molecular weight of the polymer PLP-PBA is 35 kDa-45 kDa.

[0010] Preferably, the grafting rate of aminophenylboronic acid derivatives in the polymer PLP-PBA is 1%-50%; further preferably, the grafting rate of aminophenylboronic acid derivatives is 4%-21%; more preferably, the grafting rate of aminophenylboronic acid derivatives is 12%.

[0011] The preparation method of the novel pH and glucose dual-responsive polymer PLP-PBA, whose reaction formula is shown below, specifically comprises the following steps: polylysine isophthalamide and aminophenylboronic acid derivatives are subjected to amidation reaction in a solvent under the action of a coupling reagent and a catalyst to obtain the pH and glucose dual-responsive polymer PLP-PBA.

[0012]

[0013] Preferably, the aminophenylboronic acid derivatives include at least one of 2-aminophenylboronic acid, 3-aminophenylboronic acid, 4-aminophenylboronic acid, 3-aminophenylboronic acid hydrochloride, 4-(N'-hydroxyaminoformamido)phenylboronic acid, 4-amino-3-fluorophenylboronic acid hydrochloride, 3-amino-4-methylphenylboronic acid, 3-amino-5-carboxylphenylboronic acid, 5-amino-2-fluorophenylboronic acid, 2-amino-4-carboxylphenylboronic acid, 4-(aminoethylcarbamoyl)-3-fluorophenylboronic acid, 4-(aminomethyl)-3-fluorophenylboronic acid hydrochloride, 3-(aminomethyl)-2-fluorophenylboronic acid hydrochloride, and the like.

[0014] Preferably, the coupling agent includes at least one of dicyclohexylcarbodiimide (DCC), triethylamine, diisopropylcarbodiimide (DIC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI), N-hydroxysuccinimide (NHS), 1-ethyl-(3-dimethylaminopropyl)carbodiimide (EDC), etc. Further preferably, the coupling agent is dicyclohexylcarbodiimide.

[0015] Preferably, the catalyst includes at least one of 4-N,N-dimethylpyridine (DMAP), 4-pyrrolidinylpyridine (4-PPY), 1-hydroxybenzotriazole (HOBt), etc. Further preferably, the catalyst is 4-N,N-dimethylpyridine.

[0016] Preferably, the solvent includes at least one of dimethyl sulfoxide (DMSO), NN-dimethylformamide (DMF), ethylene glycol dimethyl ether (EDG), dichloromethane, chloroform, methanol, water, etc. More preferably, the solvent is a mixed solvent of dimethyl sulfoxide and NN-dimethylformamide.

[0017] Preferably, the temperature of the amidation reaction is 10-35°C.

[0018] The preparation method of the novel pH and glucose dual-responsive polymer also includes separation and purification steps, wherein a sodium hydroxide-ethanol solution is added to the reaction solution to precipitate the polymer, and then ether, n-hexane or petroleum ether is added to dilute and remove by-products in the reaction process; the precipitated polymer is washed with alkali and acid to remove impurities.

[0019] A method for preparing a novel pH and glucose dual-responsive hydrogel comprises the following steps: PLP-PBA polymer and L-lysine methyl ester dihydrochloride (LME) are catalyzed to form an amide bond to obtain LME-(PLP-PBA) hydrogel. Furthermore, the method for preparing the hydrogel comprises the following steps: PLP-PBA polymer, L-lysine methyl ester dihydrochloride, and a catalyst are added to water or solutions of each substance are prepared separately and then mixed, the mixed solution is stirred until it changes from clear to opaque, and the LME-(PLP-PBA) hydrogel is obtained by balancing for 12-36 hours. The catalyst comprises at least one of diethyl carbonate (EDC), N-hydroxysuccinimide (NHS), etc.

[0020] Preferably, the molar ratio of amino groups in LME to carboxyl groups in PLP-PBA polymer is 0.1-50: 1, more preferably 2.5-10: 1. More preferably, the grafting rate of PBA in the PLP-PBA polymer is 12%, and the molar ratio of amino groups in LME to carboxyl groups in PLP-PBA polymer is 6.7: 1.

[0021] A novel pH and glucose dual-responsive hydrogel LME-(PLP-PBA) is obtained by the above preparation method.

[0022] The above polymer PLP-PBA or hydrogel is used as an insulin drug carrier or in the preparation of an insulin drug carrier.

[0023] Application of the above polymer PLP-PBA or hydrogel in the preparation of drugs for treating diabetes.

[0024] A drug for treating diabetes comprises the hydrogel and an insulin drug, and its preparation method comprises the following steps: immersing the hydrogel in a solution containing the insulin drug and incubating the solution so that the drug is loaded onto the hydrogel to obtain the drug for treating diabetes.

[0025] The present invention combines phenylboronic acid with polylysine isophthalamide (PLP), which can effectively reduce the pK of phenylboronic acid. a value, after adding glucose, it can form a borate ester bond with glucose, and has good glucose responsiveness. The polymer PLP-PBA also retains the original properties of PLP. At acidic pH, the carboxylic acid group of PLP is protonated, and PLP can transform from a hydrophilic irregular coil to a hydrophobic spherical conformation, causing the hydrogel to collapse and retain the loaded drug. At higher pH, the carboxylic acid group is negatively charged, causing the hydrogel to swell and release the drug. The PLP-PBA of the present invention is different from the reported glucose responsiveness containing phenylboronic acid, and its glucose responsiveness mechanism is: in the presence of glucose, the phenylboronic acid group forms a borate ester bond with glucose, so that it has good glucose responsiveness. The present invention provides a good platform for developing pH and glucose responsive systems under physiological pH conditions.

[0026] Advantages and beneficial effects of the present invention:

[0027] The invention adopts copolymerization of polylysine isophthalamide (PLP) and aminophenylboronic acid (PBA) to synthesize a polymer PLP-PBA having dual responses to pH and glucose. The polymer exhibits good pH responsiveness and glucose responsiveness.

[0028] The pH and glucose dual-responsive polymer hydrogel prepared by the present invention has an average particle size of the polymer reduced under acidic conditions, and after glucose is added, the hydrogel has a porous microstructure and swells.

[0029] The pH and glucose dual-responsive polymer and hydrogel prepared by the present invention have good pH responsiveness and glucose responsiveness, and can be used as a delivery carrier of insulin drugs for the preparation of treatment of diabetes. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 :PLP-PBA series polymers 1 H-NMR.

[0031] Figure 2 : FT-IR of PLP-PBA series polymers.

[0032] Figure 3 : Transmittance of PLP-PBA series polymers.

[0033] Figure 4 : Particle size distribution of PLP-PBA series polymers at pH 7.4 (A) and pH 6.0 (B).

[0034] Figure 5 : Different pH-dependent hemolysis (A) and optical images (B) of PLP-PBA series polymers.

[0035] Figure 6 : Gelation behavior of LME and PLP-PBA polymer at different ratios.

[0036] Figure 7 : Cytotoxicity of PLP-PBA series polymers (A) and LME-(PLP-PBA) hydrogel (B).

[0037] Figure 8 : Drug release curves of 6.7LME-(PLP-PBA-12%) (A) and 10LME-(PLP-PBA-21%) (B) hydrogels at different glucose concentrations.

[0038] Fig. 9 : Optical images (A) and swelling ratios (B) of 6.7LME-(PLP-PBA-12%) hydrogels at different pH values.

[0039] Fig.10 : Optical images (A) and swelling ratios (B) of 6.7LME-(PLP-PBA-12%) hydrogels at different glucose concentrations.

[0040] Fig.11 : SEM images of 6.7LME-(PLP-PBA-12%) hydrogel at pH 4.5 and 0 g / L glucose (A), pH 7.4 and 0 g / L glucose (B), and pH 7.4 and 4 g / L glucose (C), scale bar: 5 μm. DETAILED DESCRIPTION

[0041] The present invention is further described in detail below in conjunction with examples, but the embodiments of the present invention are not limited thereto.

[0042] The chemicals and raw materials used in the following examples are either commercially available or homemade by known preparation methods.

[0043] The preparation of the novel pH and glucose dual-responsive polymer and hydrogel provided by the present invention may specifically include the following steps:

[0044] 1. Synthesis of polymer PLP-PBA

[0045] (1) 3-aminophenylboronic acid was dissolved in a mixed solvent of dimethyl sulfoxide and NN-dimethylformamide (v(dimethyl sulfoxide):v(NN-dimethylformamide)=1:3), polylysine isophthalamide and 4-N,N-dimethylaminopyridine were dissolved in a mixed solvent of dimethyl sulfoxide and NN-dimethylformamide (v:v=1:3), and the two solutions were mixed. At the same time, dicyclohexylcarbodiimide (DCC) was dissolved in DMF, and then slowly added dropwise to the above mixed solution, and stirred at room temperature for more than 48 hours.

[0046] (2) Monitor the reaction by thin layer chromatography (CHCl3:MeOH:triethylamine=8:2:0.2 (v:v:v), using ninhydrin to visualize the amine. After the reaction is completed, vacuum filtration or centrifugation is performed to remove solid impurities. First, add about one-fourth of the volume of 5wt% NaOH ethanol solution to the reaction solution and stir to precipitate the polymer; then continue to add 5 times the volume of ether to the reaction solution, continue stirring for about 15 minutes to remove the by-products in the reaction process. Dissolve the precipitated polymer in 0.2M NaOH aqueous solution and filter the solution. Add 2M HCl to the filtrate to adjust the pH to below 3, and the polymer precipitates, vacuum filtration; the precipitated polymer is redissolved in 0.2M NaOH aqueous solution. Repeat the acid and alkali washing for 2-3 times, and finally concentrate the solution dissolved in NaOH to clarify.

[0047] (3) The polymer solution was placed in a dialysis bag (molecular weight cut-off 12-14 kDa) and dialyzed in distilled water for 3-4 days.

[0048] (4) After dialysis, in order to prepare its neutral form, it was adjusted to pH about 7.4 using 2 M NaOH aqueous solution and lyophilized to produce a neutral form of PLP-PBA.

[0049] After dialysis, in order to prepare its acidic form, the dialyzed polymer solution was acidified to pH about 3.0 with 0.2 M HCl solution. The precipitate was collected by vacuum filtration or centrifugation, washed three times with deionized water, and lyophilized to produce the acid form of PLP-PBA.

[0050] 2. Preparation of LME-(PLP-PBA) hydrogel

[0051] The obtained neutral form PLP-PBA polymer is dissolved in deionized water, and L-lysine methyl ester dihydrochloride (LME) is dissolved in deionized water. Diethyl carbonate (EDC) is used to catalyze the formation of amide bonds to synthesize the hydrogel. The steps are as follows: Add the LME solution to the neutral form PLP-PBA polymer solution and mix it at a low speed with a vortex mixer. Then quickly add the EDC solution. Stir the final mixture at room temperature for 2-5 minutes until the solution changes from clear to opaque, and stand at room temperature for 24 hours to synthesize the LME-(PLP-PBA) hydrogel. Take out the hydrogel and put it in deionized water, and store it in a refrigerator at 4°C. Change the deionized water twice a day, and continue the operation for 2-3 days to remove the unreacted reagents and monomers.

[0052] Example 1

[0053] The pH and glucose dual-responsive polymer was prepared according to the above method. The specific conditions were as follows: 166 mg (1.2 mmol), 303 mg (2.2 mmol), 500 mg (3.6 mmol) and 1500 mg (10.9 mmol) of 3-aminophenylboronic acid were dissolved in 1 mL of a mixed solvent of dimethyl sulfoxide and NN-dimethylformamide (v:v=1:3). 3 g of polylysine isophthalamide (Mw=35700, 0.08 mmol) and 0.6 g of 4-N,N-dimethylaminopyridine were dissolved in 60 mL of a mixed solvent of dimethyl sulfoxide and NN-dimethylformamide (v:v=1:3). The two solutions were mixed, and a DCC solution (1.2 g DCC dissolved in 10 mL of DMF solution) was slowly added dropwise. The mixture was stirred at room temperature for more than 48 h, and the polymers PLP-PBA with 3-aminophenylboronic acid grafting rates of 4%, 8%, 12%, and 21% were obtained after separation (Table 1).

[0054] Table 1 Feed ratio and grafting rate of PLP-PBA series polymers

[0055]

[0056] The acid form of the polymer PLP-PBA was dissolved in d6-DMSO. 1 H-NMR nuclear magnetic resonance instrument records the 1 H-NMR spectrum. The ratio of the integral ~10.01 ppm to the integral 1.43-1.86 ppm was used to calculate the grafting rate of each polymer, which represents the number of PBA grafted per 100 carboxyl groups on the PLP backbone (mol %).

[0057] The acid form of PLP and PLP-PBA series polymers were freeze-dried, mixed with potassium bromide and ground into powder, which was then pressed into transparent tablets using an oil press. The Fourier transform infrared spectrometer was used to analyze the-1 The test was carried out within a wavenumber range, and the data were plotted as a transmittance versus wavenumber function curve, and the infrared spectra (FT-IR) of the PLP and PLP-PBA series polymers were recorded. The amide I band is usually at 1640-1680cm -1 Characteristic peaks appear in the range of 3110-3520 cm-1, indicating the stretching vibration of the C=O group. -1 A weak absorption band appears at 1540cm -1 The two bands are the doublet frequency peaks of the -NH group at 40 nm and 80 nm, respectively. These two bands can be used to determine the structure and composition of compounds containing amide groups.

[0058] pass 1 H-NMR and FT-IR spectra confirmed the synthesis of PLP-PBA-4%, PLP-PBA-8%, PLP-PBA-12% and PLP-PBA-21% ( Figure 1 , 2).

[0059] Example 2

[0060] 1.0 mg / mL neutral PLP-PBA polymer solutions with different grafting rates at different pH were prepared using PBS buffer (0.1 M) or citrate buffer (0.1 M) by pH meter testing and allowed to stand at room temperature for 48 h. The transmittance of the polymer was tested at 480 nm using a UV-visible spectrophotometer.

[0061] Results Figure 3 At a polymer concentration of 1.0 mg / mL, pH-mediated phase separation was observed in the PLP-PBA polymer, indicating that 3-PBA side chain modification with a certain degree of grafting does not affect the pH responsiveness of the polymer. Compared with PLP, the pH value at which the hydrophobic association of the PLP-PBA polymer begins increases, and the precipitation pH range becomes wider, which is due to the enhanced hydrophobicity of the grafted hydrophobic PBA side chain. Under the same pH conditions, the higher the grafting rate, the lower the transmittance of the polymer.

[0062] Example 3

[0063] Dynamic light scattering: Dynamic light scattering (DLS) was used to study the size distribution of PLP-PBA polymers with different grafting rates. The neutral form of the polymer was dissolved in pH 6.0 or pH 7.4 PBS buffer to prepare a 1.0 mg / mL polymer solution, which was allowed to stand at room temperature for more than 48 hours. After the solution to be tested was filtered with a 0.45 μm filter membrane, it was added to a sample cell with a diameter of 10 mm, and the dynamic light scattering was measured at 25 ° C with a scattering angle of 137 °, and each run was repeated 11 times.

[0064] The particle size distribution of polymer PLP and PLP-PBA with different grafting ratios at pH 7.4 (A) and pH 6.0 (B) is shown in Figure 2. Figure 4 ,With the increase of the grafting density, the group structure shows a transformation from a bimodal to a single modal structure, the main reason is the increase of the hydrophobic phenylboronic acid groups, and the hydrophobic effect plays a dominant role, forming a more compact single size group structure.

[0065] Example 4

[0066] The membrane activity of PLP-PBA polymers was examined using a hemolytic assay of ICR mouse red blood cells (RBCs). The neutral form of the polymer was added to a pH 4.5, 5.0 citrate buffer or a pH 5.5, 6.0, 6.5, 7.0, 7.4 PBS buffer at a polymer concentration of 1.0 mg / mL. RBCs were washed at least three times with a pH 7.4 PBS buffer and added to the polymer solution to a concentration of approximately 1.5 × 10 8 RBCs mL -1 The final concentration of . Negative control (no polymer added) and positive control (water) were prepared at the same cell density, and the samples were incubated in a shaking water bath at 37°C for 1 h. Hemoglobin release was studied by measuring the absorbance of the supernatant at 540 nm using a UV-Vis spectrophotometer. The relative hemolysis percentage was calculated using the following formula.

[0067]

[0068] Among them, OD S Refers to the absorbance of the experimental group samples, OD b Refers to the absorbance of the negative control group, OD c is the absorbance of the positive control group.

[0069] Results Figure 5 , as the grafting rate increases, the hydrophobicity of the polymer increases, and the relative hemolytic activity increases in the pH range of 4.5-7.4. Under the condition of pH 6.0, PLP and PLP-PBA series polymers show relatively large hemolysis. Under weak acidic conditions of pH 6.0, the hydrophobic effect is dominant, which promotes PLP and PLP-PBA series polymers to insert into the cell membrane or fuse with the cell membrane, showing relatively large hemolysis and strong cell membrane destruction ability. Under strong acid conditions, the PLP main chain in the PLP-PBA series polymers undergoes a conformational change from a hydrophilic irregular linear structure to a hydrophobic spherical structure, resulting in a weaker ability of the polymer to bind to the cell membrane, showing relatively low hemolysis. Under neutral conditions of pH 7.4, the side chain carboxyl groups of the PLP-PBA series polymers are deprotonated and negatively charged, and electrostatic repulsion occurs with the negatively charged cell membrane, and the cell membrane is almost not hemolyzed.

[0070] Example 5

[0071] 10.08 mg of neutral form of PLP-PBA-8% was dissolved in 150 μL of deionized water, and 3.65 mg of LME was dissolved in 50 μL of deionized water. The obtained PLP-PBA polymer solution and LME solution were mixed at low speed with a vortex mixer, and then 50 μL of 100 mg / mL EDC solution was added. The final mixture was stirred at room temperature for 2-5 minutes until the solution changed from clear to opaque, and was allowed to stand at room temperature for 24 hours to obtain a 2.5LME-(PLP-PBA-8%) hydrogel with a molar ratio of amino to carboxyl groups of 2.5. The hydrogel was taken out and placed in deionized water and stored in a refrigerator at 4°C. The deionized water was changed twice a day for 2-3 days to remove unreacted reagents and monomers.

[0072] 10.08 mg of neutral form of PLP-PBA-12% was dissolved in 150 μL of deionized water, and 1.39 mg of LME was dissolved in 50 μL of deionized water. The obtained PLP-PBA polymer solution and LME solution were mixed at low speed with a vortex mixer, and then 50 μL of 100 mg / mL EDC solution was added. The final mixture was stirred at room temperature for 2-5 min until the solution changed from clear to opaque, and was allowed to stand at room temperature for 24 h to obtain 6.7 LME-(PLP-PBA-12%) hydrogel. The hydrogel was taken out and placed in deionized water and stored in a refrigerator at 4°C. The deionized water was changed twice a day for 2-3 days to remove the unreacted reagents and monomers.

[0073] 10.08 mg of neutral form of PLP-PBA-21% was dissolved in 150 μL of deionized water, and 0.91 mg of LME was dissolved in 50 μL of deionized water. The obtained PLP-PBA polymer solution and LME solution were mixed at low speed with a vortex mixer, and then 50 μL of 100 mg / mL EDC solution was added. The final mixture was stirred at room temperature for 2-5 min until the solution turned from clear to opaque, and was allowed to stand at room temperature for 24 h to obtain 10 LME-(PLP-PBA-21%) hydrogel. The hydrogel was taken out and placed in deionized water and stored in a refrigerator at 4°C. The deionized water was changed twice a day for 2-3 days to remove the unreacted reagents and monomers.

[0074] According to the above method, different ratios of LME and PLP-PBA polymers were selected to prepare hydrogels, and their gelation was observed. The formation of hydrogels is affected by the degree of crosslinking and the modification of polymer side chains. As the ratio of LME to PLP-PBA polymers increases, the degree of crosslinking increases. Hydrogels are formed at higher LME:PLP-PBA ratios ( Figure 6). In addition, the side chain grafting degree significantly affected the formation of hydrogels. For the side chains grafted with 8% PBA, LME-PLP-PBA 8% hydrogels were formed at all LME:polymer ratios. When the grafting ratio was increased to 12%, hydrogels with LME:polymer ratios of 10 and 6.7 were formed. At a grafting degree of 21%, hydrogels were only formed at a LME:polymer ratio of 10. This may be due to the side chain modification reducing the number of carboxyl groups that can crosslink with amino groups.

[0075] Example 6

[0076] The cultured cells in the logarithmic phase were digested, centrifuged, and counted. 100 μL 3k-7k / well 3T3 cells were inoculated on a 96-well plate and cultured for 24 hours at 37°C, 5% CO2, and 90% humidity. Neutral polymer solutions of different concentrations (0.01 mg / mL, 0.1 mg / mL, 0.5 mg / mL, 1.0 mg / mL, 5.0 mg / mL, and 10.0 mg / mL) and hydrogel extracts (25 mg hydrogel dissolved in 10 mL pH 7.4 PBS buffer was 100%, and then diluted to 25%, 50%, and 75%), and 200 μL of the sample solution was inoculated into a 96-well plate and cultured for 24 hours under the same conditions. 10 μL MTT solution was added to each well to a final concentration of 0.5 mg / mL, and cultured for 4 hours under the same conditions. Aspirate all the supernatant in the wells and add 100 μL of formazan solution to each well. Place the cell plate on a constant temperature shaker at 37°C and 100 rpm for 15 minutes to dissolve the formazan completely. Finally, use an ELISA reader to measure the absorbance at 562 nm and calculate the cell survival rate:

[0077]

[0078] Among them, OD S Refers to the absorbance of the experimental group, OD c Refers to the absorbance of the control group, OD b is the absorbance of the blank group.

[0079] In the concentration range of 0.01-10.0 mg / mL, after 24 hours of treatment of 3T3 cells with four polymers, PLP-PBA-4%, PLP-PBA-8%, PLP-PBA-12% and PLP-PBA-21%, the cell survival rate was above 80%, and no cytotoxicity was shown. Further testing of 2.5LME-(PLP-PBA-8%), 6.7LME-(PLP-PBA-12%) and 10LME-(PLP-PBA-21%) hydrogels prepared with three different formulas also showed no cytotoxicity after 24 hours of treatment ( Figure 7 ).

[0080] Example 7

[0081] 80 mg of 6.7LME-(PLP-PBA-12%) hydrogel and 10LME-(PLP-PBA-21%) hydrogel were placed in pH 7.4 PBS buffer at 4°C for 48 hours, then immersed in 0.5 mg / mL FITC-labeled insulin solution to load insulin and incubated at 4°C for 24 hours. The hydrogel loaded with insulin was transferred from 4°C to 37°C dilute hydrochloric acid (1%) and soaked for about 1 minute to induce the formation of the hydrogel smart layer. The hydrogel was taken out and rinsed with deionized water, and placed in 3mL of glucose solution with concentrations of 0g / L, 1g / L, and 4g / L, respectively, and placed in a 37°C constant temperature shaker. 500μL of supernatant was taken at predetermined time intervals and replaced with an equal amount of fresh corresponding glucose concentration solution to keep the volume constant. The fluorescence intensity of released insulin was measured by a fluorescence spectrophotometer at an excitation wavelength of 490 nm and an emission wavelength of 520 nm, and the cumulative amount of drug released was calculated.

[0082] Results Figure 8 There was no significant difference in the insulin release amount of 10LME-(PLP-PBA-21%) hydrogel loaded with insulin at different glucose concentrations, and its glucose responsiveness was not obvious; while 6.7LME-(PLP-PBA-12%) hydrogel was able to release more insulin at a glucose concentration of 4g / L, and its glucose responsiveness was good.

[0083] Example 8

[0084] The swelling properties of the hydrogel were investigated by swelling experiments. The 6.7LME-(PLP-PBA-12%) hydrogel was immersed in PBS buffers with different pH values ​​and glucose concentrations for 24 hours to reach swelling equilibrium, and then weighed. The swelling ratio was calculated according to the following formula:

[0085]

[0086] Where M0 is the dry weight of the hydrogel, M t is the wet mass of hydrogel at different glucose concentrations.

[0087] The hydrogel was quickly frozen with liquid nitrogen, and the freeze-dried sample was coated with a gold coater. The internal microstructure of the sample was observed using a scanning electron microscope.

[0088] The swelling ratio of 6.7LME-(PLP-PBA-12%) hydrogel after equilibrium at different pH and glucose concentrations is shown in Fig. 9 , 10, when the glucose concentration was 0 g / L, the diameter of the 6.7LME-(PLP-PBA-12%) hydrogel increased at pH 7.4. When the pH dropped to 4.5, the diameter of the hydrogel decreased, indicating that the hydrogel shrank under acidic conditions. At neutral pH, when the glucose concentration reached 4 g / L, the diameter increased significantly compared to the diameter at 0 g / L at the same pH, indicating that the hydrogel swelled under high sugar concentration conditions. These results demonstrate that the 6.7LME-(PLP-PBA-12%) hydrogel is responsive to both glucose and pH. The network structure of the gel was observed by SEM, and the 6.7LME-(PLP-PBA-12%) hydrogel after equilibrium in a glucose concentration of 4 g / L had a microstructure with relatively large pores ( Fig.11 ), which is beneficial to the controlled release of drugs.

[0089] The above embodiments are only used to help illustrate the present invention. The implementation methods of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A pH and glucose dual-responsive polymer, characterized in that: The polymer is polylysine isophthalamide grafted with aminophenylboronic acid derivatives.

2. The pH and glucose dual responsive polymer according to claim 1, characterized in that: The structure of the polymer is shown below: Among them, one of R1-R5 is B(OH)2, and the other four are one or more of hydrogen, halogen, amino, hydroxyl, methyl, ethyl, carboxyl, aminomethyl, aminoethyl, formyl, and formylamino.

3. The pH and glucose dual responsive polymer according to claim 1, characterized in that: The grafting rate of the polymer PLP-PBA and the aminophenylboronic acid derivative is 1%-50%.

4. The method for preparing the pH and glucose dual-responsive polymer according to any one of claims 1 to 3, characterized in that: The following steps are involved: The polylysine isophthalamide and the aminophenylboronic acid derivative undergo an amidation reaction in a solvent under the action of a coupling reagent and a catalyst to obtain the pH and glucose dual-responsive polymer.

5. The preparation method according to claim 4, characterized in that: The coupling agent includes at least one of dicyclohexylcarbodiimide, triethylamine, diisopropylcarbodiimide, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, N-hydroxysuccinimide, and 1-ethyl-(3-dimethylaminopropyl)carbodiimide; The catalyst comprises at least one of 4-N, N-dimethylpyridine, 4-pyrrolidinopyridine and 1-hydroxybenzotriazole.

6. A method for preparing a pH and glucose dual-responsive hydrogel, characterized in that: The following steps are involved: The pH and glucose dual-responsive polymer described in any one of claims 1 to 3 and L-lysine methyl ester dihydrochloride are catalyzed by a catalyst to form an amide bond to obtain the hydrogel.

7. The preparation method according to claim 6, characterized in that: The molar ratio of the amino group in L-lysine methyl ester dihydrochloride to the carboxyl group in the pH and glucose dual responsive polymer is 0.1-50:

1.

8. A pH and glucose dual-responsive hydrogel, characterized in that: The method is obtained by the preparation method according to claim 6 or 7.

9. Use of the pH and glucose dual-responsive polymer according to any one of claims 1 to 3 or the pH and glucose dual-responsive hydrogel according to claim 8, characterized in that: The application includes any one of the following: application as an insulin drug carrier, application in the preparation of an insulin drug carrier, and application in the preparation of a drug for treating diabetes.

10. A drug for treating diabetes, characterized in that: The invention comprises the hydrogel according to claim 8 and an insulin-like drug.

Citation Information

Patent Citations

  • Copolymer, glucose sensitive micelle, glucose sensitive medicine-carrying micelle and preparation method thereof

    CN102391504A

  • Amino-terminated ionic liquid grafted polylysine isophthalamide as well as synthesis method and application thereof in low-temperature preservation of cells

    CN113354809A

  • Preparation method of glucose-triggered active oxygen response injection type composite hydrogel

    CN113599507A

  • Glucose and H2O2 dual-response double-layer cross-linked polymer nano drug delivery system as well as preparation method and application thereof

    CN114668745A

  • Poly(l-lysine isolphthalamide) (PLP) polymers with hydrophobic pendant chains

    US20190248956A1